Could ketamine be the game-changer in safe sedation practices within interventional radiology? Recent research suggests it might be. While traditional sedation often relies on opioids—drugs that can cause serious breathing issues and extend hospital stays—a new approach using ketamine combined with midazolam offers a promising alternative, especially in light of ongoing shortages of anesthesiology providers. But here’s where it gets controversial: can we safely perform complex procedures without the direct oversight of an anesthesiologist?
A recent study, published in the Journal of Vascular and Interventional Radiology, involved over 900 procedures—all performed using ketamine and midazolam without the usual anesthesiology support. Alarmingly, there were virtually no serious respiratory problems. Patients didn’t require intubation, and there were no significant heart or lung complications linked to the sedation.
Dr. Amy R. Deipolyi, a respected interventional radiologist and one of the study’s lead authors, emphasized the significance of these findings. She explained that opioid-associated respiratory depression is a major concern—linked to increased healthcare costs and longer hospital stays—and that ketamine appears to carry a much lower risk of such issues. This safety advantage could revolutionize how sedation is managed in interventional radiology, especially in clinics facing staffing challenges.
The study was carried out at a single medical center toward the end of 2025. The hospital established strict policies and procedures to allow nonanesthesia providers to administer ketamine safely. These protocols included detailed steps such as enhanced provider training—requiring certifications in advanced cardiovascular life support and basic life support—and close supervision during procedures, including airway management with oral or nasal devices, observed directly by an anesthesiologist. Interventional radiologists also had to complete supervised cases before performing unsupervised sedation.
While these results are promising, the broader question remains: can this method be universally adopted? And is it truly safer or merely a reflection of highly controlled conditions? What do you think—is ketamine ready to be a standard sedation option outside the traditional anesthesiology domain? Or should we proceed with caution? Share your thoughts below—this topic might ignite a debate about safety, training, and innovation in patient care.
